Digistain
Digistain is a medical technology company that uses an AI-driven spectral signature platform to assess breast cancer recurrence risk at the point-of-care with same day turnaround, costing half the price for more efficient clinical-decisioning.
Operating in health and life sciences based in London, England, United Kingdom, Digistain operates.
The company sits in the health and life sciences segment, where it competes on its core product or service.
Its base of operations is London, England, United Kingdom.
Its current recorded stage is Summer 2021.
Its team size is recorded as 40 employees.
| Sector | Health and Life Sciences |
|---|---|
| Headquarters | London, England, United Kingdom |
| Country | United Kingdom |
| Employees | 40 |
| Stage | Summer 2021 |
Website: digistain.co.uk
Sign in to view the contact information we hold for Digistain.
Create a free account
Create a free account